Hyderabad rising in biotech, pharma, medtech innovation: Revanth Reddy

Hyderabad:  Chief Minister A Revanth Reddy said Hyderabad was India’s emerging hub of biotech, pharma, and medical technology innovation, with the ambition to become a $1 trillion economy by 2034. He assured total support on behalf of the State government for innovation in medical products.

Speaking at the Biodesign Innovation Summit at AIG Hospital on Sunday, the Chief Minister said Hyderabad had moved from manufacturing to innovation, driven by strong academic institutions, skill development, and industry partnerships. Assuring total government support for indigenous medical innovation to solve the nation’s medical needs, he offered access to historical medical data for innovators and researchers, while maintaining strict privacy safeguards.

“For years, our best minds have been solving problems in other countries. Now, the time has come to use our intelligence to help our own people,” he said, emphasising MedTech’s critical role in healthcare transformation.

Revanth Reddy said the Medical Devices Park at Sultanpur was India’s largest, housing over 60 global and domestic companies with infrastructure for research, testing, and manufacturing. Telangana’s ecosystem of startups, MSMEs, and global corporations makes Hyderabad a vibrant destination for Life Sciences, he added.

Related Posts

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

The National Pharmaceutical Pricing Authority (NPPA) has said that it is not mandatory for the oncology drug manufacturers who are revising the drug prices as per the recently announced Trade…

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

GLP-1 injections recalled across the US over sterility concerns

GLP-1 injections recalled across the US over sterility concerns

Govt allows third-party agencies to conduct departmental inspections

Govt allows third-party agencies to conduct departmental inspections

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

Fridge-free vaccines could reach more people, but there are still practical challenges in African settings